(DOX) Amdocs - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: GB0022569080
DOX: Software, Services, Cloud, Networking, Billing, Management, Automation
Amdocs Limited is a leader in providing software and services to the communications, media, and entertainment industries. The companys solutions are designed to empower service providers in a rapidly evolving digital landscape. Amdocs offers a range of innovative products, including CES24, a suite of GenAI-driven assistants powered by the amAIz platform, aimed at transforming business operations. Additionally, the Amdocs Subscription Marketplace is a SaaS platform that aggregates a wide range of digital services, from media and gaming to eLearning and security, simplifying access for providers. The company also provides Amdocs connectX, a cloud-native, telco-in-a-box solution, and Amdocs eSIM Cloud, which addresses the growing demand for embedded SIM technology.
Amdocs service portfolio extends beyond software, encompassing consulting, experience design, data analytics, cloud services, and network solutions. They offer end-to-end support, including system integration, quality engineering, and managed services that leverage AI, predictive analytics, and robotic process automation. This comprehensive approach helps clients navigate digital transformation, optimize operations, and enhance customer experiences.
Headquartered in Saint Louis, Missouri, Amdocs has been a key player in the industry since its founding in 1982. The companys strategic focus on emerging technologies such as 5G, IoT, and cloud-native solutions positions it as a critical partner for telecom operators and media companies. Amdocs commitment to innovation and customer-centric solutions underscores its role in shaping the future of digital services.
Ticker Symbol: DOX
Exchange: NASDAQ
Country Origin: United States
GICS Sub Industry: IT Consulting & Other Services
Market Cap or AUM: 9699.05M USD
P/E: 19.90
P/E Forward: 12.39
P/B: 2.80
P/S: 1.94
Additional Sources for DOX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DOX Stock Overview
Market Cap in USD | 9,962m |
Sector | Technology |
Industry | Software - Infrastructure |
GiC Sub-Industry | IT Consulting & Other Services |
IPO / Inception | 1998-06-19 |
DOX Stock Ratings
Growth 5y | 43.8% |
Fundamental | 37.9% |
Dividend | 65.2% |
Rel. Strength Industry | -15.4 |
Analysts | 4.71/5 |
Fair Price Momentum | 82.41 USD |
Fair Price DCF | 78.18 USD |
DOX Dividends
Dividend Yield 12m | 2.22% |
Yield on Cost 5y | 3.02% |
Annual Growth 5y | 7.87% |
Payout Consistency | 99.2% |
DOX Growth Ratios
Growth Correlation 3m | 25.3% |
Growth Correlation 12m | 16.4% |
Growth Correlation 5y | 84.6% |
CAGR 5y | 6.77% |
CAGR/Max DD 5y | 0.20 |
Sharpe Ratio 12m | -0.22 |
Alpha | -12.62 |
Beta | 0.47 |
Volatility | 17.76% |
Current Volume | 726.7k |
Average Volume 20d | 728.3k |
As of February 22, 2025, the stock is trading at USD 88.00 with a total of 726,673 shares traded.
Over the past week, the price has changed by -0.34%, over one month by +2.68%, over three months by +3.87% and over the past year by +0.43%.
Partly, yes. Based on ValueRay Fundamental Analyses, Amdocs (NASDAQ:DOX) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.91 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOX as of February 2025 is 82.41. This means that DOX is currently overvalued and has a potential downside of -6.35%.
Amdocs has received a consensus analysts rating of 4.71. Therefor, it is recommend to buy DOX.
- Strong Buy: 5
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DOX Amdocs will be worth about 94 in February 2026. The stock is currently trading at 88.00. This means that the stock has a potential upside of +6.76%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 102.5 | 16.5% |
Analysts Target Price | 102.1 | 16% |
ValueRay Target Price | 94 | 6.8% |